BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35411612)

  • 21. NAA20 recruits Rin2 and promotes triple-negative breast cancer progression by regulating Rab5A-mediated activation of EGFR signaling.
    Qiao L; Dong C; Jia W; Ma B
    Cell Signal; 2023 Dec; 112():110922. PubMed ID: 37827343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
    Han C; Fu Y; Zeng N; Yin J; Li Q
    Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
    Luo N; Zhang K; Li X; Hu Y
    J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CPNE1 mediates glycolysis and metastasis of breast cancer through activation of PI3K/AKT/HIF-1α signaling.
    Cao J; Cao R; Liu Y; Dai T
    Pathol Res Pract; 2023 Aug; 248():154634. PubMed ID: 37454492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
    Wang X; Chen T; Zhang Y; Zhang N; Li C; Li Y; Liu Y; Zhang H; Zhao W; Chen B; Wang L; Yang Q
    J Cell Physiol; 2019 Aug; 234(8):13303-13317. PubMed ID: 30618083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. USP6NL mediated by LINC00689/miR-142-3p promotes the development of triple-negative breast cancer.
    Ma T; Liu H; Liu Y; Liu T; Wang H; Qiao F; Song L; Zhang L
    BMC Cancer; 2020 Oct; 20(1):998. PubMed ID: 33054738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.
    Umar SM; Kashyap A; Kahol S; Mathur SR; Gogia A; Deo SVS; Prasad CP
    Exp Cell Res; 2020 Nov; 396(1):112282. PubMed ID: 32919954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H19 promotes aerobic glycolysis, proliferation, and immune escape of gastric cancer cells through the microRNA-519d-3p/lactate dehydrogenase A axis.
    Sun L; Li J; Yan W; Yao Z; Wang R; Zhou X; Wu H; Zhang G; Shi T; Chen W
    Cancer Sci; 2021 Jun; 112(6):2245-2259. PubMed ID: 33756038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-489 suppresses multiple myeloma cells growth through inhibition of LDHA-mediated aerobic glycolysis.
    Wu H; Wang X; Wu T; Yang S
    Genes Genomics; 2020 Mar; 42(3):291-297. PubMed ID: 31872383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of Kinase Family 15 Inhibits Cancer Cell Proliferation In vitro and its Clinical Relevance in Triple-Negative Breast Cancer.
    Sheng J; Xue X; Jiang K
    Curr Mol Med; 2019; 19(2):147-155. PubMed ID: 30854965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a.
    Huang X; Xie X; Wang H; Xiao X; Yang L; Tian Z; Guo X; Zhang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 Sep; 36(1):129. PubMed ID: 28915924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Characterization of lncRNA152 as an Angiogenesis-Inhibiting Tumor Suppressor in Triple-Negative Breast Cancers.
    Kim DS; Camacho CV; Setlem R; Kim K; Malladi S; Hou TY; Nandu T; Gadad SS; Kraus WL
    Mol Cancer Res; 2022 Nov; 20(11):1623-1635. PubMed ID: 35997635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
    Zuo Y; Li Y; Zhou Z; Ma M; Fu K
    Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
    Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KCNK1 promotes proliferation and metastasis of breast cancer cells by activating lactate dehydrogenase A (LDHA) and up-regulating H3K18 lactylation.
    Hou X; Ouyang J; Tang L; Wu P; Deng X; Yan Q; Shi L; Fan S; Fan C; Guo C; Liao Q; Li Y; Xiong W; Li G; Zeng Z; Wang F
    PLoS Biol; 2024 Jun; 22(6):e3002666. PubMed ID: 38905316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D; Jia H; Zhang Z; Li S
    Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression.
    Huang TT; Tseng LM; Chen JL; Chu PY; Lee CH; Huang CT; Wang WL; Lau KY; Tseng MF; Chang YY; Chiang TY; Ueng YF; Lee HC; Dai MS; Liu CY
    EBioMedicine; 2020 Apr; 54():102717. PubMed ID: 32268268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non‑coding RNA SChLAP1 regulates the proliferation of triple negative breast cancer cells via the miR‑524‑5p/HMGA2 axis.
    Bai X; Zhang S; Qiao J; Xing X; Li W; Zhang H; Xie J
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.